[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

CO6801754A2 - A pharmaceutical composition for treating a disease in the oral cavity comprising rebamipide - Google Patents

A pharmaceutical composition for treating a disease in the oral cavity comprising rebamipide

Info

Publication number
CO6801754A2
CO6801754A2 CO13250727A CO13250727A CO6801754A2 CO 6801754 A2 CO6801754 A2 CO 6801754A2 CO 13250727 A CO13250727 A CO 13250727A CO 13250727 A CO13250727 A CO 13250727A CO 6801754 A2 CO6801754 A2 CO 6801754A2
Authority
CO
Colombia
Prior art keywords
rebamipide
disease
treating
pharmaceutical composition
oral cavity
Prior art date
Application number
CO13250727A
Other languages
Spanish (es)
Inventor
Takakuni Matsuda
Nobutomo Sako
Takako Nakashima
Kazushi Sakurai
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of CO6801754A2 publication Critical patent/CO6801754A2/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/47042-Quinolinones, e.g. carbostyril
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Dispersion Chemistry (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CO13250727A 2011-03-24 2013-10-22 A pharmaceutical composition for treating a disease in the oral cavity comprising rebamipide CO6801754A2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2011066353 2011-03-24

Publications (1)

Publication Number Publication Date
CO6801754A2 true CO6801754A2 (en) 2013-11-29

Family

ID=45932481

Family Applications (1)

Application Number Title Priority Date Filing Date
CO13250727A CO6801754A2 (en) 2011-03-24 2013-10-22 A pharmaceutical composition for treating a disease in the oral cavity comprising rebamipide

Country Status (16)

Country Link
US (1) US20140010882A1 (en)
EP (1) EP2688552A1 (en)
JP (2) JP5841167B2 (en)
KR (1) KR20140020289A (en)
CN (1) CN103429224A (en)
AR (1) AR085527A1 (en)
AU (1) AU2012232062B2 (en)
BR (1) BR112013024034A2 (en)
CA (1) CA2829107A1 (en)
CO (1) CO6801754A2 (en)
EA (1) EA201391379A1 (en)
MX (1) MX2013010971A (en)
SG (1) SG193391A1 (en)
TW (1) TWI547281B (en)
UA (1) UA114600C2 (en)
WO (1) WO2012128394A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015034008A1 (en) * 2013-09-05 2015-03-12 大塚製薬株式会社 Use of rebamipide for local hemostasis
CN104586762A (en) * 2014-04-11 2015-05-06 广州仁恒医药科技有限公司 Rebamipide-containing drug composition and preparation method thereof
CN105878245B (en) * 2015-01-07 2017-12-15 珠海亿胜生物制药有限公司 A kind of preparation method of Rebamipide water slurry
AU2016226280C1 (en) 2015-03-02 2020-09-24 Medlab Clinical U.S., Inc. Transmucosal and transdermal delivery systems
WO2018189587A1 (en) 2017-04-14 2018-10-18 Capsugel Belgium Nv Process for making pullulan
CN110678170A (en) 2017-04-14 2020-01-10 比利时胶囊公司 Pullulan polysaccharide capsule
KR101923519B1 (en) 2018-06-26 2019-02-27 대우제약 주식회사 A water-soluble, multi-use eyedrops composition for the treatment of dry eye syndrome containing rebamipide and a method for solubilization and stabilization thereof
JP7132774B2 (en) 2018-07-09 2022-09-07 日綜産業株式会社 mobile scaffolding
KR20200019451A (en) 2018-08-14 2020-02-24 대우제약 주식회사 A water-soluble, multi-use eyedrops composition for the treatment of dry eye syndrome containing rebamipide and a method for solubilization and stabilization thereof
ES2913792T3 (en) * 2019-09-03 2022-06-06 Square Power Ltd Rebamipide for use in the prophylaxis and treatment of celiac disease
CN114053242A (en) * 2021-11-19 2022-02-18 苏州天马医药集团天吉生物制药有限公司 Rebamipide tablet and preparation method thereof
KR102659338B1 (en) * 2023-05-18 2024-04-19 국제약품 주식회사 A pharmaceutical composition for treating dry eye syndrome

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995011026A1 (en) 1993-10-21 1995-04-27 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivative for inhibiting production of interleukin-8
JP3093661B2 (en) 1995-10-12 2000-10-03 大塚製薬株式会社 Eye disease treatment
US20030195179A1 (en) * 2000-08-25 2003-10-16 Shirou Sawa Aqueous suspension preparations
JP2002255852A (en) 2001-03-01 2002-09-11 Toa Eiyo Ltd Spray preparation for stomatitis
NZ532759A (en) * 2001-10-10 2005-10-28 Boehringer Ingelheim Pharma Powder processing with pressurized gaseous fluids
ATE373502T1 (en) 2003-07-30 2007-10-15 Otsuka Pharma Co Ltd CARBOSTYRIL DERIVATIVES FOR ACCELERATED SALIVA
TWI363626B (en) 2004-11-15 2012-05-11 Otsuka Pharma Co Ltd Aqueous ophthalmic suspension of crystalline rebamipide
JP5288791B2 (en) * 2005-01-28 2013-09-11 武田薬品工業株式会社 Miniaturized composition containing a hardly water-soluble substance
TW200808375A (en) * 2006-05-12 2008-02-16 Otsuka Pharma Co Ltd Hydrogel suspension and manufacturing process thereof
TWI415629B (en) * 2006-10-26 2013-11-21 Otsuka Pharma Co Ltd Aqueous pharmaceutical suspensions containing rebamipide and manufacturing process thereof
CN101778626B (en) * 2007-08-10 2014-05-07 大塚制药株式会社 Medical composition containing rebamipide

Also Published As

Publication number Publication date
EA201391379A1 (en) 2014-06-30
AU2012232062A1 (en) 2013-09-26
US20140010882A1 (en) 2014-01-09
JP5841167B2 (en) 2016-01-13
NZ614970A (en) 2016-01-29
AU2012232062B2 (en) 2017-04-20
TWI547281B (en) 2016-09-01
JP6101332B2 (en) 2017-03-22
MX2013010971A (en) 2013-10-07
CN103429224A (en) 2013-12-04
SG193391A1 (en) 2013-10-30
CA2829107A1 (en) 2012-09-27
UA114600C2 (en) 2017-07-10
BR112013024034A2 (en) 2016-12-13
AR085527A1 (en) 2013-10-09
EP2688552A1 (en) 2014-01-29
WO2012128394A1 (en) 2012-09-27
TW201244718A (en) 2012-11-16
KR20140020289A (en) 2014-02-18
JP2016094417A (en) 2016-05-26
JP2014508721A (en) 2014-04-10

Similar Documents

Publication Publication Date Title
CO6801754A2 (en) A pharmaceutical composition for treating a disease in the oral cavity comprising rebamipide
CR20130406A (en) PHARMACEUTICAL COMPOSITIONS THAT INCLUDE HUMAN ANTIBODIES AGAINST PCSK9
BRPI0905717A2 (en) Pharmaceutical composition, process for preparing a pharmaceutical composition and pharmaceutical dosage form
CO6900149A2 (en) A pharmaceutical composition comprising the phytocannabinoids Canabidivarine (CBDV) and Canabidiol (CBD)
BR112015003332A2 (en) compound, pharmaceutical composition, use of the compound and method for treating a rorgammat-mediated disease or condition in a patient
BR112015003398A2 (en) compound, pharmaceutical composition, use of the compound and method for treating a rorgammat-mediated disease or condition in a patient
BR112013015203A2 (en) oral care dispenser
DK2694038T3 (en) PHARMACEUTICAL COMPOSITION
BRPI1008598A2 (en) pharmaceutical composition for inhalation
BR112013033072A2 (en) apoptosis inducing agent and pharmaceutical composition
BR112014006689A2 (en) oral care composition
CO6950486A2 (en) Solution for oral administration
BR112014015042A2 (en) pharmaceutical composition, and method for obtaining a radiopharmaceutical composition
BRPI1007161A2 (en) oral pharmaceutical composition, and process for preparing a composition
BRPI1007484A2 (en) pharmaceutical composition for oral administration
CO6940426A2 (en) Pharmaceutical formulations
DK2815752T3 (en) ORAL PHARMACEUTICAL COMPOSITION
BRPI0925100A2 (en) osmotic dosage form and process for preparing an osmotic dosage form
BRPI1007211A2 (en) oral pharmaceutical composition in a solid form, and process for preparing a composition.
CO6920289A2 (en) Topical ophthalmic pharmaceutical composition containing regorafenib.
BRPI0918539A2 (en) solid pharmaceutical preparation for oral administration
BR112014012497A2 (en) oral care composition, oral cavity disinfection method and use
CO7010828A2 (en) Pharmaceutical preparation comprising substituted ßcyclodextrin
BR112013019518A2 (en) oral care compositions.
BR112013029637A2 (en) oral care compositions

Legal Events

Date Code Title Description
FC Application refused